ShockWave Medical, Inc.
SWAV · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $7 | $7 | $6 | $3 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $0 | $0 | $0 |
| Enterprise Value | $7 | $7 | $6 | $3 |
| Revenue | $1 | $0 | $0 | $0 |
| % Growth | 49.1% | 106.5% | 249.8% | – |
| Gross Profit | $1 | $0 | $0 | $0 |
| % Margin | 86.9% | 86.7% | 82.5% | 69% |
| EBITDA | $0 | $0 | -$0 | -$0 |
| % Margin | 26.1% | 26% | -0.4% | -93.2% |
| Net Income | $0 | $0 | -$0 | -$0 |
| % Margin | 20.2% | 44.1% | -3.9% | -96.9% |
| EPS Diluted | 3.85 | 5.7 | -0.26 | -1.99 |
| % Growth | -32.5% | 2,292.3% | 86.9% | – |
| Operating Cash Flow | $0 | $0 | $0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | -$0 |